Viagra First Quarter Sales: What Goes Up Must Come Down
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer is planning several "competitive responses" to help the erectile dysfunction agent Viagra (sildenafil) rebound from a disappointing first quarter, the company told analysts during an April 20 earnings call